Kyverna Therapeutics, Inc. (KYTX)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
7. 8200
-0.08
-1.01%
$
376.17M Market Cap
- P/E Ratio
- Div Yield
802,629 Volume
- Eps
$ 7.9
Previous Close Want to track KYTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kyverna Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 222,929 | $1.78M | $1.74M | -$33,330.15 | -1.88% |
| BB Bryan Buchert Kera Capital Partners Inc. | 132,603 | $465,191.26 | $1.04M | $571,764.2 | 122.91% |
| PLC Peapod Lane Capital LLC Peapod Lane Capital LLC | 40,404 | $78,597.69 | $315,959.28 | $237,361.59 | 302% |
| FDW Fourth Dimension Wealth LLC Fourth Dimension Wealth LLC | 250 | $935 | $1,955 | $1,020 | 109.09% |
| GFM GF Fund Management Co. Ltd. GF Fund Management Co. Ltd. | 977 | $3,928.98 | $7,640.14 | $3,711.16 | 94.46% |
